ð¥çä¹³ã¢ã¬ã«ã®ãŒãšå¿èç ã®æå€ãªé¢é£æ§ïŒææ°ç ç©¶ãç€ºãæ°ããªèŠç¹
ç§ãã¡ã®èº«è¿ãªé£åã§ããçä¹³ã¯ãå€ãã®äººã«ãšã£ãŠæ é€è±å¯ãªé£²ã¿ç©ã§ãããäžéšã®äººã ã«ãšã£ãŠã¯ã¢ã¬ã«ã®ãŒã®åå ãšãªããŸãããããŸã§ãçä¹³ã¢ã¬ã«ã®ãŒãšå¿èç ã®é¢é£ã«ã€ããŠã¯ãç¹å®ã®å ç«ã°ãããªã³EïŒIgEïŒãšããæäœãå¿è¡ç®¡çŸæ£ã«ããæ»äº¡ãªã¹ã¯ãšé¢é£ããå¯èœæ§ãææãããŠããŸããããããããã®é¢é£ãå ·äœçã«ã©ã®ãããªå¿èç ã€ãã³ãããªã¹ã¯å åãšçµã³ã€ãã®ãããã®è©³çްã¯ãŸã äžæãªç¹ãå€ãã£ãã®ã§ãã
ä»åã玹ä»ããç ç©¶ã¯ãçä¹³ã«å¯ŸããIgEæäœïŒã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããå¯èœæ§ã®ããç¶æ ïŒããå¿èç ã®å ·äœçãªã€ãã³ããããã®ãªã¹ã¯ãé«ããèŠå ãšã©ã®ããã«é¢é£ããŠããã®ãã詳ãã調æ»ãããã®ã§ãããã®ç ç©¶ã¯ãçä¹³ã¢ã¬ã«ã®ãŒãæã€äººã ã ãã§ãªããå¿èã®å¥åº·ã«é¢å¿ã®ãããã¹ãŠã®äººã«ãšã£ãŠãæ°ããªæ å ±ãæäŸãããããããŸããã
ð¬ç ç©¶ã®ç®çãšèæ¯
ãã®ç ç©¶ã®äž»ãªç®çã¯ãçä¹³ç¹ç°çIgEæäœããå¿çæ¢å¡ãè³åäžãšãã£ãå¿è¡ç®¡çŸæ£ïŒCVDïŒã€ãã³ããããã³å åèç³ç°åïŒCACïŒãå«ãå¿èç ã®ãªã¹ã¯å¢åŒ·å åãšã©ã®ãããªé¢é£ãããã®ããæããã«ããããšã§ããããããŸã§ã®å€§èŠæš¡ãªéå£ããŒã¹ã®ç ç©¶ã§ã¯ãçä¹³ç¹ç°çIgEãšå¿è¡ç®¡çŸæ£ã«ããæ»äº¡çãšã®é¢é£ã瀺åãããŠããŸãããããããå ·äœçãªèšåºçã¢ãŠãã«ã ãå¿è¡ç®¡ãªã¹ã¯ã«ã©ãåæ ããããã¯äžæã§ããã
ç ç©¶è ãã¡ã¯ããã®çåã«çããããšã§ãçä¹³ã¢ã¬ã«ã®ãŒãæã€äººã ã®å¿èç ãªã¹ã¯è©äŸ¡ã«åœ¹ç«ã€æ°ããªç¥èŠãåŸãããšããŸããã
ð§ªç ç©¶ã®æ¹æ³
ãã®ç ç©¶ã¯ãè€æ°ã®ç é¢ãããªãå»çã·ã¹ãã ã«æå±ãã50æ³ä»¥äžã®æäººã察象ãšããåŸåãã«ã«ãã¬ãã¥ãŒâ»1ãšããŠå®æœãããŸããã察象æ£è ã¯ãè¡æž äžã®é£ç©ç¹ç°çIgEæ€æ»ãåãã人ã ã§ãã
- 察象æ£è
ã®åé¡:
- çä¹³IgEé°æ§ïŒ0.10 kU/LæªæºïŒ
- å¢çåïŒ0.10ïœ0.35 kU/LïŒ
- æäœããïŒ0.35 kU/Lè¶ ïŒ
ãã ããèšåºçã«çä¹³ã¢ã¬ã«ã®ãŒãšèšºæãããŠããæ£è ã¯ããã®ç ç©¶ããé€å€ãããŸãããããã¯ãã¢ã¬ã«ã®ãŒçç¶ãã®ãã®ãå¿èç ã«åœ±é¿ãäžããå¯èœæ§ãæé€ãããããšèããããŸãã
- è©äŸ¡é
ç®:
å¿çæ¢å¡ãè³è¡ç®¡çºäœïŒè³åäžïŒãå åèçŸæ£ããããŠå åèç³ç°åïŒCACïŒâ»2ãšãã£ãå¿è¡ç®¡çŸæ£é¢é£ã®ã€ãã³ãããªã¹ã¯å åãè©äŸ¡ãããŸããããããã®æ å ±ã¯ã2012幎ãã2024幎ãŸã§ã®é»åã«ã«ããCPT/ICDã³ãŒãâ»3ãããã³ç»å蚺æã¬ããŒãããåéãããŸããã - ããŒã¿è§£æ:
ã«ã€äºä¹æ€å®ãWilcoxonæ€å®ããããŠäººå£çµ±èšåŠçå åã䜵åçŸæ£ã調æŽããå€å€éã¢ãã«ãçšããŠãçä¹³IgEæäœãšå¿è¡ç®¡çŸæ£ã€ãã³ãããªã¹ã¯å åãšã®é¢é£ãçµ±èšçã«åæãããŸããã
â»1 åŸåãã«ã«ãã¬ãã¥ãŒïŒéå»ã®èšºçèšé²ïŒã«ã«ãïŒãé¡ã£ãŠèª¿æ»ããç¹å®ã®çŸæ£ãæ²»çæ³ãšçµæã®é¢é£ãåæããç ç©¶æ¹æ³ã§ãã
â»2 å åèç³ç°åïŒCACïŒïŒå¿èã«è¡æ¶²ãéãå åèã®å£ã«ã«ã«ã·ãŠã ãæ²çããçŸè±¡ã§ãåè硬åã®é²è¡åºŠã瀺ãéèŠãªææšã®äžã€ã§ãã
â»3 CPT/ICDã³ãŒãïŒå»çè¡çºã蚺æåãæšæºåãããã³ãŒãã§è¡šããã®ã§ãé»åã«ã«ãããã®ããŒã¿æœåºã«çšããããŸãã
ðäž»ãªç ç©¶çµæã®ãã€ã³ã
ãã®ç ç©¶ã«ã¯åèš1,220äººã®æ£è ãåå ããŸããïŒå¹³å幎霢64.4æ³ã女æ§63.6%ïŒããã®ãã¡113人ïŒ9.3%ïŒãçä¹³IgEæäœãããšåé¡ãããŸãããäž»èŠãªçµæã¯ä»¥äžã®éãã§ãã
| è©äŸ¡é ç® | çä¹³IgEæäœãšã®é¢é£ | è©³çŽ°ïŒæäœãã vs é°æ§ïŒ | çµ±èšçæææ§ |
|---|---|---|---|
| å¿è¡ç®¡ã€ãã³ã ïŒå¿çæ¢å¡ãè³è¡ç®¡çºäœãå åèçŸæ£ãªã©ïŒ |
é¢é£ãªã | çä¹³æäœç¶æ ã«ããå·®ã¯èªãããã | å·®ãªã |
| LDL-P ïŒäœå¯åºŠãªãã¿ã³ãã¯è³ªç²åæ°ïŒâ»4 |
é«å€ã®é¢é£ãã | çä¹³IgEãé«ã矀ã§é«å€ | p < .001 |
| é«æåºŠCRP ïŒå šèº«æ§ççããŒã«ãŒïŒâ»5 |
é¢é£ãªã | çä¹³æäœãšã®é¢é£ã¯èªãããã | å·®ãªã |
| å åèç³ç°åïŒCACïŒ ïŒãµããµã³ãã« n=104ïŒ |
ææãªé«å€ã®é¢é£ãã | äžå€®å€ïŒ885.8 Agatston units vs 145.2 Agatston units | p < .0001 |
â»4 LDL-PïŒäœå¯åºŠãªãã¿ã³ãã¯è³ªç²åæ°ïŒïŒãããããæªçã³ã¬ã¹ãããŒã«ããéã¶ç²åã®æ°ãæããåè硬åã®ãªã¹ã¯ãè©äŸ¡ããææšã®äžã€ã§ãã
â»5 é«æåºŠCRPïŒäœå ã®ççã®çšåºŠã瀺ãè¡æ¶²æ€æ»ã®ããŒã«ãŒã§ãå¿è¡ç®¡çŸæ£ã®ãªã¹ã¯è©äŸ¡ã«ãçšããããŸãã
ç¹ã«æ³šç®ãã¹ãã¯ãå¿è¡ç®¡ã€ãã³ããå šèº«æ§ççããŒã«ãŒïŒé«æåºŠCRPïŒãšã¯é¢é£ãèŠãããªãã£ãäžæ¹ã§ãå åèç³ç°åïŒCACïŒã«ã€ããŠã¯ãçä¹³IgEæäœãããçŸ€ã§ææã«é«ãå€ã瀺ãããç¹ã§ãããã®CACã®é¢é£ã¯ãçä¹³IgEã®ã¬ãã«ãäžããã«ã€ããŠCACã®å€ãé«ããªããšãããçšéäŸåçãªé¢ä¿ãšããŠèгå¯ãããŸããã
ð€ç ç©¶ã®èå¯ãšæ°ããªèŠç¹
ãã®ç ç©¶çµæã¯ãçä¹³ç¹ç°çIgEæäœããèšåºçãªå¿è¡ç®¡ã€ãã³ãïŒå¿çæ¢å¡ãè³åäžãªã©ïŒãå šèº«æ§ã®ççããŒã«ãŒãšã¯çŽæ¥çãªé¢é£ã瀺ããªãããšãæããã«ããŸãããããã¯ãéå»ã«IgEãšå¿è¡ç®¡æ»äº¡çã®é¢é£ã瀺åããç ç©¶ãšã¯ç°ãªãçµæã§ãããè峿·±ãç¹ã§ãã
ããããå åèç³ç°åïŒCACïŒãšã®éã«ã¯ãçä¹³IgEæäœãšçšéäŸåçãªé¢ä¿ãèªããããŸãããç ç©¶è ãã¡ã¯ããã®CACã®å¢å ããç³ç°åããŠãããæœåšçã«ããå®å®ãããã©ãŒã¯ïŒåè硬åå·£ïŒã®çç©åŠã«ãã£ãŠèª¬æãããå¯èœæ§ãææããŠããŸããã€ãŸããIgEæäœãåè硬åã®é²è¡ã«é¢äžãããã®ã®ããããå¿ ãããäžå®å®ãªãã©ãŒã¯ã®ç Žè£ã«ããæ¥æ§å¿è¡ç®¡ã€ãã³ãã«çŽçµããããã§ã¯ãªãããšããå¯èœæ§ã瀺åããŠããã®ã§ãã
LDL-Pãé«å€ã§ãã£ããšããçµæããåè硬åã®ããã»ã¹ãšã®é¢é£ã瀺åããŸãããNMRæ€æ»ïŒLDL-Pãæž¬å®ããæ€æ»ïŒãåããæ£è æ°ãå°ãªãã£ãããããã®é¢é£ã«ã€ããŠã¯ãããªãæ€èšŒãå¿ èŠã§ãã
ð¡å®ç掻ãžã®ã¢ããã€ã¹
ä»åã®ç ç©¶çµæã¯ãçä¹³ã¢ã¬ã«ã®ãŒïŒIgEæäœïŒãšå¿èç ã®é¢é£ã«ã€ããŠãããã€ãã®éèŠãªç€ºåãäžããŸãããçŸæç¹ã§ããã«çæŽ»ç¿æ £ã倧ããå€ããã¹ãã ãšããçµè«ã«ã¯è³ã£ãŠããŸããã
- é床ãªå¿é ã¯äžèŠ: çä¹³IgEæäœããããããšãã£ãŠãçŽã¡ã«å¿çæ¢å¡ãè³åäžã®ãªã¹ã¯ãåçã«é«ãŸãããšããçŽæ¥çãªèšŒæ ã¯ä»åã®ç ç©¶ã§ã¯èŠãããŸããã§ããã
- å åèç³ç°åïŒCACïŒãžã®æ³šæ: CACãé«ããšããçµæã¯ãå°æ¥çãªå¿èç ãªã¹ã¯ã®ææšãšãªãåŸãŸãããããèªèº«ãçä¹³IgEæäœããããå¿èç ã®ãªã¹ã¯å åïŒé«è¡å§ãé«ã³ã¬ã¹ãããŒã«ãç³å°¿ç ãå«ç ãªã©ïŒããæã¡ã®å Žåã¯ããããã€ãå»ãšçžè«ãã宿çãªå¥åº·ãã§ãã¯ãåããããšãéèŠã§ãã
- ãæäœããšãã¢ã¬ã«ã®ãŒãã®éã: ãã®ç ç©¶ã§å¯Ÿè±¡ãšãªã£ãã®ã¯ãçä¹³IgEæäœãã§ãããå¿ ãããèšåºçãªãçä¹³ã¢ã¬ã«ã®ãŒãçç¶ã䌎ã人ã ã§ã¯ãããŸãããå®éã«çä¹³ã¢ã¬ã«ã®ãŒã®çç¶ãããæ¹ã¯ãå»åž«ã®æç€ºã«åŸããé©åãªé£äºç®¡çãè¡ãããšãæåªå ã§ãã
- äžè¬çãªå¿èç äºé²ã®ç¶ç¶: ãã©ã³ã¹ã®åããé£äºãé©åºŠãªéåãçŠç ãã¹ãã¬ã¹ç®¡çãªã©ãå¿èç äºé²ã®ããã®äžè¬çãªå¥åº·ç¿æ £ã¯ããã¹ãŠã®äººã«ãšã£ãŠåŒãç¶ãéèŠã§ãã
- èªå·±å€æããå°éå®¶ãžçžè«: ãããèªèº«ã®IgEæäœãå¿èã®å¥åº·ã«ã€ããŠæžå¿µãããå Žåã¯ãå¿ ãå»åž«ãå°éå®¶ã«ãçžè«ãã ããã
ð§ç ç©¶ã®éçãšä»åŸã®èª²é¡
ãã®ç ç©¶ã¯éèŠãªç¥èŠããããããŸããããããã€ãã®éçãååšããŸãã
- åŸåãç ç©¶ã§ããããš: éå»ã®ããŒã¿ã«åºã¥ããŠãããããçä¹³IgEæäœãšå¿èç ã®å æé¢ä¿ãæç¢ºã«ç¹å®ããããšã¯å°é£ã§ãã
- CACãµããµã³ãã«ã®å°ãã: å åèç³ç°åïŒCACïŒã®ããŒã¿ãåŸãããæ£è æ°ãæ¯èŒçå°ãªãã£ãïŒ104人ïŒããããã®çµæãäžè¬åããã«ã¯ãããªãå€§èŠæš¡ãªç ç©¶ãå¿ èŠã§ãã
- èšåºççä¹³ã¢ã¬ã«ã®ãŒæ£è ã®é€å€: å®éã«ã¢ã¬ã«ã®ãŒçç¶ãæã€æ£è ãé€å€ãããŠãããããèšåºçãªçä¹³ã¢ã¬ã«ã®ãŒãšå¿èç ã®é¢é£ã«ã€ããŠã¯ããã®ç ç©¶ããã¯çµè«ãåºããŸããã
- ã¡ã«ããºã ã®äžæç¢ºã: IgEæäœããªãCACã®å¢å ãšé¢é£ããã®ãããã®å ·äœçãªçç©åŠçã¡ã«ããºã ã¯ãŸã è§£æãããŠããŸããã
ãããã®éçãèžãŸããç ç©¶è ãã¡ã¯ãä»åŸãååãç ç©¶â»6ã«ãã£ãŠæéçãªé¢ä¿æ§ãã¡ã«ããºã ãè©äŸ¡ããä»åã®ç¥èŠãèšåºçã«ã©ã®ãããªæå³ãæã€ã®ããããã«æç¢ºã«ããå¿ èŠããããšæèšããŠããŸãã
â»6 ååãç ç©¶ïŒç¹å®ã®éå£ãäžå®æé远跡ããå°æ¥çºçããçŸæ£ãã€ãã³ããšãçŸåšã®å åãšã®é¢é£ã調ã¹ãç ç©¶æ¹æ³ã§ãã
ãŸãšã
ä»åã®ç ç©¶ã¯ãçä¹³ç¹ç°çIgEæäœããå¿çæ¢å¡ãè³åäžãšãã£ãå ·äœçãªå¿è¡ç®¡ã€ãã³ããå šèº«æ§ççããŒã«ãŒãšã¯çŽæ¥çãªé¢é£ã瀺ããªãäžæ¹ã§ãå åèç³ç°åïŒCACïŒãšã¯çšéäŸåçãªé¢é£ãããããšãæããã«ããŸããããã®çµæã¯ãçä¹³IgEæäœãåè硬åã®é²è¡ã«é¢äžããå¯èœæ§ã瀺åãããã®ã®ããããå¿ ãããæ¥æ§å¿è¡ç®¡ã€ãã³ãã«çŽçµããããã§ã¯ãªããšãããæ°ããªèŠç¹ãæäŸããŸããçŸæç¹ã§ã¯ãçä¹³IgEæäœããããããšãã£ãŠé床ã«å¿é ããå¿ èŠã¯ãããŸããããå¿èã®å¥åº·å šè¬ã«ãããæ³šæãšãä»åŸã®ãããªãç ç©¶ãåŸ ãããŸãããèªèº«ã®å¥åº·ç¶æ ã«äžå®ãããå Žåã¯ãå¿ ãå»çå°éå®¶ã«ãçžè«ãã ããã
ðé¢é£ãªã³ã¯é
æžèªæ å ±
| DOI | pii: S1081-1206(26)00147-X. doi: 10.1016/j.anai.2026.03.025 |
|---|---|
| PMID | 41936963 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/41936963/ |
| çºè¡å¹Ž | 2026 |
| èè å | Davies Sara, Orendain Natalia, Canty Ethan A, Khan Najah A, Abud Edsel M, White Andrew A |
| èè æå± | Allergy, Asthma and Immunology, Scripps Clinic, San Diego, California, USA; Scripps Green Hospital, 403c, 10666 N. Torrey Pines Road, La Jolla, CA 92037. Electronic address: Davies.Sara@scrippshealth.org.; Department of Research & Development, Scripps Health, La Jolla, CA, United States.; Allergy, Asthma and Immunology, Scripps Clinic, San Diego, California, USA.; Division of Cardiology, Scripps Clinic, La Jolla, CA, United States of America. |
| éèªå | Ann Allergy Asthma Immunol |